Prudential Financial Inc Soleno Therapeutics Inc Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $15,041 - $20,469	-15,507 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$1.24 - $3.3 $1,992 - $5,303	1,607 Added 11.56%	15,507 $20,000
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $23,769 - $34,889	13,900 New	13,900 $35,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.